Background: The present study evaluated use of chemical method to determine components and category of urinary stones described in current stone disease guidelines.
Introduction
Urinary system stone disease is more frequently seen in developed countries, with prevalence that varies between 1% and 20%. [1, 2] In addition to obesity, metabolic syndrome, and type 2 diabetes, [3, 4] factors such as calcium-deficient diet, and diet rich in salt and animal protein increase the incidence of the disease. [2, 5] More than 100 chemical components have been defined in urinary system stones; however, multiple underlying molecular mechanisms of the disease have not been clarified yet. [6] Stone analysis is important in order to be able to prevent recurrence. In all cases of recurrence [2, 7] following long-term stone-free period achieved with pharmacological treatment, chemical analysis of the stone is recommended. [2] Since most urinary system stones are composed of complex components, chemical methods of analysis frequently prove to be inadequate. [8, 9] Methods of stone analysis currently used include infrared spectroscopy (IRS), X-ray diffraction (XRD), and polarization microscope. Although not very popular, chemical analysis ("wet" analysis) can also be used. [2, 10] This study was an investigation of the effectiveness of chemical method for analysis of components and categorization of urinary stones as described in current European Association of Urology (EAU) guidelines.
Patients and Methods
Chemical analysis of stones was performed in the clinical biochemistry laboratory of Gülhane Military Medical Academy with the approval of the Gülhane Military Medical Academy Ethics Committee between March 2014 and September 2015. Stone samples brought in by patients and those removed using ureteroscopy or during percutaneous renal surgery were crushed into small fragments with mechanical lithotriptors. Fragments were then divided among 8 test tubes. Composition of urinary system stone was analyzed according to instructions of LTA Kidney Stone Analysis Kit manufacturer (AB Analitica, Padova, Italy). Calcium, oxalate, magnesium, phosphate, uric acid, ammonium, cysteine, and carbonate found in the stones were analyzed quantitatively. Any stones too small to be divided among 8 test tubes were not included in the analysis. Results of chemical analysis were retrospectively analyzed. Stones were grouped according to number of mineral components: 1, 2 or ≥3. Components were compared with types of stone described in guidelines.
Results
A total of 198 urinary system stones were analyzed. Majority (n=133; 67.1%) consisted of multiple mineral components, while single component was found in remainder (n=65; 32.9%).
Analysis results of 107 (54%) samples were consistent with EAU guideline description. Composition consisted of calcium oxalate (n=45; 22.7%), calcium phosphate (n=22; 11.6%), calcium and uric acid (n=11; 6.1%), uric acid (n=10; 5%), cysteine (n=7; 3.5%), carbonate apatite (n=4; 2%), ammonium urate (n=4; 2%), and magnesium ammonium phosphate (n=1; 0.5%).
Chemical analysis of 91 (46%) stone samples revealed mineral components and combinations of components that are not in current EAU guidelines, including magnesium phosphate (n=27; 13.6%); phosphate (n=22; 11.1%); magnesium (n=18; 9%); magnesium, calcium, and phosphate (n=10; 5%); calcium and magnesium (n=5; 2.5%); magnesium and ammonium (n=2; 1%); ammonium phosphate (n= 2: 1%); uric acid and phosphate (n=2; 1%), ammonium phosphate and urate (n=1; 0.5%); magnesium, ammonium, and calcium (n=1; 0.5%); and calcium phosphate, magnesium, and urate (n=1; 0.5%) ( Table 1) .
Discussion
Urinary system stone disease is a prevalent health problem affecting millions of people worldwide. In developed countries, most often upper urinary system stones are seen; however, in developing countries, endemic infantile bladder lithiasis may be seen. [1] Prevalence rate of stone disease in the United States of America has been reported as nearly 12% and 6% among male and female populations, respectively. [11] Turkey has a high (15%) incidence of urinary system stone disease. [12] Furthermore, high recurrence rate within 5 and 10 years after first painful episode of stone disease (50% and 80-90%, respectively) mandates pursuit of an effective strategy for diagnosis, treatment, and follow-up of this disease. [13] In order to prevent not only urinary system diseases, but also bone, parathyroid, and many endocrine disorders, as well as their related complications, metabolic evaluation guidelines should be complied with, and stone analysis should be first among these assessments. For correct classification, in addition to evaluation of basic laboratory tests, urinalysis, i.e., microscopic examination of urine sample and/or urine culture, serum creat-inine, uric acid, calcium, sodium, potassium, C-reactive protein (CRP), whole blood count, and a reliable stone analysis should be performed. [2, 14] Variation in composition of stone from initial sample may occur over time, and subsequent stone may be of still another composition; therefore, analysis should be repeated in recurrent cases. [15, 16] Stone analysis can reveal risk factors for stone disease, as well as identify treatment targeted to prevent stone formation or dissolve an existing stone (litholysis). [10] Stones containing brushite (CaHPO4.2H 2 O), uric acid, and urate signal high risk for recurrence. [2] Stone analysis assists in establishment of diagnosis of specific metabolic disorders and can indicate if the patient would benefit from shock wave lithotripsy. In addition, it can reveal drug metabolites, such as triamterene and indanavir, which can induce stone formation. [15] Method to be used for stone analysis may vary according to type of sample, cost-effectiveness of method, lengthy duration of analysis, and experience of the analyst. [17] Most frequently used methods of stone analysis include XRD, IRS, and polarization microscope. Each method has its own advantages and disadvantages. [10, 18] Low error rate and cost-effectiveness have made IRS most preferred method. [19] Rapid results and ability to analyze even small stones with high degree of accuracy are additional advantages of this method. [19] Chemical stone analysis method permits quantitative and qualitative determination of limited number of ions. It does not allow for identification of crystaloid structures. For instance, it cannot discriminate between calcium oxalate monohydrate and dihydrate stones. Furthermore, chemical analysis cannot identify xanthine, 2,8 -Dihydroxyadenine, or medicationrelated stones. Error rates for this method have been reported as 6-94% and 13-47% for stones with 1 and 2 mineral components, respectively. [19] 197 n % Stones described in EAU guidelines (n=107; 54%) Table 1 . Types of stones and components detected in the study
In our study, 107 (54%) stones with single or multiple mineral components as detected by our chemical analysis were in accordance with stone types indicated in EAU guidelines (Table 2) , while 91 (46%) were not described in the guidelines. Most frequently, calcium oxalate (22%) and calcium phosphate (11.6%) stones were detected. In another study performed in this country with 6453 patients, most common types of stones found were whewellite (calcium oxalate monohydrate) (55.7%), whellite plus weddellite (calcium oxalate dihydrate) (18.8%), and weddellite: 5.9%). [12] Data we obtained as a result of chemical method of analysis of urinary system stones were not consistent with the literature data, and did not meet current guidelines. Stone composition has important role in patient monitoring, appropriate dietary recommendations, and arrangement of pharmacotherapies, and should be determined with greater accuracy. Inaccurate results may lead to problems in diagnosis, treatment, and follow-up.
Conclusion
Urinary system stone disease is a widely seen health problem. Stone analysis is an indispensable part of diagnosis and treatment of this disease. Since treatment is different depending on stone type, establishment of accurate analysis and diagnosis is of utmost 
